Transaction in Own Shares

PureTech Health PLC
20 November 2023
 

20 November 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

17 November 2023



Number of ordinary shares purchased:

44,415



Highest price paid per share:

181.00p



Lowest price paid per share:

170.60p



Volume weighted average price paid per share:

176.95p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,355,414 ordinary shares in treasury and has 273,112,745 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 273,112,745 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

17/11/2023

08:10:56

542

175

XLON

00378753931TRLO0.1.1

17/11/2023

08:10:56

148

174.8

BATE

00378753932TRLO0.1.1

17/11/2023

08:10:56

320

174.8

BATE

00378753933TRLO0.1.1

17/11/2023

08:24:56

10

176.6

AQXE

00378755804TRLO0.1.1

17/11/2023

08:24:56

3

176.6

AQXE

00378755805TRLO0.1.1

17/11/2023

08:31:03

173

176.6

AQXE

00378756925TRLO0.1.1

17/11/2023

09:17:38

1626

177.8

XLON

00378764050TRLO0.1.1

17/11/2023

09:19:19

314

179

XLON

00378764475TRLO0.1.1

17/11/2023

09:19:19

542

179

CHIX

00378764474TRLO0.1.1

17/11/2023

09:19:19

1312

179

XLON

00378764476TRLO0.1.1

17/11/2023

10:41:18

497

181

CHIX

00378777415TRLO0.1.1

17/11/2023

10:41:18

45

181

CHIX

00378777414TRLO0.1.1

17/11/2023

10:41:18

1084

180.8

XLON

00378777416TRLO0.1.1

17/11/2023

11:02:33

542

180.6

CHIX

00378781357TRLO0.1.1

17/11/2023

11:02:33

468

180.6

BATE

00378781358TRLO0.1.1

17/11/2023

11:02:33

18

180.6

BATE

00378781359TRLO0.1.1

17/11/2023

11:02:33

1084

180.6

XLON

00378781360TRLO0.1.1

17/11/2023

11:22:25

1084

179.8

XLON

00378783887TRLO0.1.1

17/11/2023

11:22:25

186

179.8

AQXE

00378783886TRLO0.1.1

17/11/2023

11:22:25

542

179.2

CHIX

00378783888TRLO0.1.1

17/11/2023

11:22:47

94

178.8

TRQX

00378783908TRLO0.1.1

17/11/2023

12:10:23

1084

178

XLON

00378790606TRLO0.1.1

17/11/2023

12:11:26

186

177.6

AQXE

00378790745TRLO0.1.1

17/11/2023

12:37:28

284

177.8

XLON

00378794120TRLO0.1.1

17/11/2023

12:37:28

2461

177.8

XLON

00378794121TRLO0.1.1

17/11/2023

12:38:08

711

178

XLON

00378794196TRLO0.1.1

17/11/2023

12:38:08

617

178

XLON

00378794197TRLO0.1.1

17/11/2023

12:38:11

107

178

CHIX

00378794203TRLO0.1.1

17/11/2023

12:38:15

338

177.4

CHIX

00378794209TRLO0.1.1

17/11/2023

12:38:15

31

177.4

CHIX

00378794210TRLO0.1.1

17/11/2023

12:38:15

86

177.4

CHIX

00378794211TRLO0.1.1

17/11/2023

12:38:34

28

178

XLON

00378794239TRLO0.1.1

17/11/2023

12:38:34

1085

178

XLON

00378794240TRLO0.1.1

17/11/2023

12:45:37

776

178

XLON

00378795059TRLO0.1.1

17/11/2023

12:54:41

123

178

XLON

00378796280TRLO0.1.1

17/11/2023

12:54:41

173

178

XLON

00378796282TRLO0.1.1

17/11/2023

12:54:41

246

178

XLON

00378796281TRLO0.1.1

17/11/2023

13:04:56

13

178

XLON

00378797688TRLO0.1.1

17/11/2023

13:04:56

529

178

XLON

00378797687TRLO0.1.1

17/11/2023

13:16:38

542

178

XLON

00378799432TRLO0.1.1

17/11/2023

13:28:23

542

178

XLON

00378801540TRLO0.1.1

17/11/2023

13:29:37

94

178

TRQX

00378801805TRLO0.1.1

17/11/2023

13:31:45

372

178

CHIX

00378802399TRLO0.1.1

17/11/2023

13:31:45

150

178

CHIX

00378802400TRLO0.1.1

17/11/2023

13:31:56

94

178

TRQX

00378802446TRLO0.1.1

17/11/2023

13:35:22

542

178

XLON

00378803241TRLO0.1.1

17/11/2023

13:41:39

227

178

XLON

00378804659TRLO0.1.1

17/11/2023

13:41:39

146

178

XLON

00378804658TRLO0.1.1

17/11/2023

13:41:39

169

178

XLON

00378804660TRLO0.1.1

17/11/2023

13:44:47

468

177.4

BATE

00378805390TRLO0.1.1

17/11/2023

13:44:47

103

177.4

BATE

00378805391TRLO0.1.1

17/11/2023

13:44:47

1084

177.6

XLON

00378805392TRLO0.1.1

17/11/2023

13:44:47

48

177.4

BATE

00378805394TRLO0.1.1

17/11/2023

13:44:47

317

177.4

BATE

00378805393TRLO0.1.1

17/11/2023

13:44:47

542

177.4

CHIX

00378805395TRLO0.1.1

17/11/2023

14:05:18

94

178

TRQX

00378809790TRLO0.1.1

17/11/2023

14:18:06

114

177

BATE

00378812727TRLO0.1.1

17/11/2023

14:30:57

212

177.8

CHIX

00378815969TRLO0.1.1

17/11/2023

14:30:57

330

177.8

CHIX

00378815968TRLO0.1.1

17/11/2023

14:32:09

88

177.8

TRQX

00378816513TRLO0.1.1

17/11/2023

14:39:01

10

177.8

BATE

00378819561TRLO0.1.1

17/11/2023

14:39:21

491

177.2

XLON

00378819671TRLO0.1.1

17/11/2023

14:39:21

1135

177.2

XLON

00378819672TRLO0.1.1

17/11/2023

14:39:21

56

177

BATE

00378819673TRLO0.1.1

17/11/2023

14:39:21

125

177

CHIX

00378819674TRLO0.1.1

17/11/2023

14:39:21

542

177

CHIX

00378819675TRLO0.1.1

17/11/2023

14:39:21

63

177

CHIX

00378819676TRLO0.1.1

17/11/2023

14:39:21

354

177

CHIX

00378819677TRLO0.1.1

17/11/2023

14:39:21

560

177

BATE

00378819679TRLO0.1.1

17/11/2023

14:39:21

280

177

BATE

00378819678TRLO0.1.1

17/11/2023

14:39:21

94

176.4

TRQX

00378819680TRLO0.1.1

17/11/2023

14:39:21

94

176.4

TRQX

00378819681TRLO0.1.1

17/11/2023

14:47:19

602

176.2

XLON

00378825658TRLO0.1.1

17/11/2023

14:48:57

1000

176.2

XLON

00378827396TRLO0.1.1

17/11/2023

14:48:57

24

176.2

XLON

00378827397TRLO0.1.1

17/11/2023

14:48:57

1144

176.2

XLON

00378827398TRLO0.1.1

17/11/2023

14:49:21

186

175.8

AQXE

00378827758TRLO0.1.1

17/11/2023

14:49:21

300

176.6

AQXE

00378827760TRLO0.1.1

17/11/2023

14:49:21

258

177

AQXE

00378827761TRLO0.1.1

17/11/2023

14:49:28

366

174.2

BATE

00378827843TRLO0.1.1

17/11/2023

14:50:25

381

170.6

XLON

00378828422TRLO0.1.1

17/11/2023

14:50:49

560

171

XLON

00378828666TRLO0.1.1

17/11/2023

15:22:01

463

175.2

CHIX

00378842561TRLO0.1.1

17/11/2023

15:22:01

139

175

AQXE

00378842562TRLO0.1.1

17/11/2023

15:22:01

79

175.2

CHIX

00378842563TRLO0.1.1

17/11/2023

15:22:01

443

175

BATE

00378842564TRLO0.1.1

17/11/2023

15:22:01

25

175

BATE

00378842565TRLO0.1.1

17/11/2023

15:22:01

1084

175

XLON

00378842566TRLO0.1.1

17/11/2023

15:22:01

100

175

TRQX

00378842567TRLO0.1.1

17/11/2023

15:22:01

47

175

AQXE

00378842568TRLO0.1.1

17/11/2023

16:02:28

542

174.8

CHIX

00378857021TRLO0.1.1

17/11/2023

16:02:29

277

174.8

XLON

00378857022TRLO0.1.1

17/11/2023

16:02:29

335

174.8

XLON

00378857023TRLO0.1.1

17/11/2023

16:14:33

542

174.2

CHIX

00378862631TRLO0.1.1

17/11/2023

16:14:34

1626

174.2

XLON

00378862637TRLO0.1.1

17/11/2023

16:14:34

22

174.2

AQXE

00378862639TRLO0.1.1

17/11/2023

16:14:34

164

174.2

AQXE

00378862640TRLO0.1.1

17/11/2023

16:14:34

457

174

XLON

00378862641TRLO0.1.1

17/11/2023

16:14:34

94

174

TRQX

00378862642TRLO0.1.1

17/11/2023

16:14:40

450

174.2

BATE

00378862666TRLO0.1.1

17/11/2023

16:18:06

308

172.6

XLON

00378863860TRLO0.1.1

17/11/2023

16:18:51

6

173.6

AQXE

00378864086TRLO0.1.1

17/11/2023

16:25:51

257

173

XLON

00378866383TRLO0.1.1

17/11/2023

16:25:51

180

173

AQXE

00378866384TRLO0.1.1

17/11/2023

16:25:51

29

173

BATE

00378866385TRLO0.1.1

17/11/2023

16:25:51

164

173

BATE

00378866386TRLO0.1.1

17/11/2023

16:27:21

244

173.6

XLON

00378867112TRLO0.1.1

17/11/2023

16:29:43

7

173.6

TRQX

00378868129TRLO0.1.1

17/11/2023

16:29:46

87

173.6

TRQX

00378868254TRLO0.1.1

17/11/2023

16:29:47

728

173.6

XLON

00378868260TRLO0.1.1

17/11/2023

16:29:47

652

173.6

XLON

00378868259TRLO0.1.1

17/11/2023

16:29:48

15

173.6

XLON

00378868275TRLO0.1.1

17/11/2023

16:29:51

7

173.6

XLON

00378868347TRLO0.1.1

17/11/2023

16:29:51

183

173.6

XLON

00378868348TRLO0.1.1

17/11/2023

16:29:55

244

173.6

XLON

00378868418TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings